Role of Sindooradi Malahama in the management of old wound.
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2021/03/031849
- Lead Sponsor
- Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Classical Dushta Vrana Lakshanas.
Atisamvritta â?? Ativivritta.
Atikathina â??Atimridu.
Utsanna-Avsanna.
Atishita-Atiushna etc.
Modern sign and symptoms of chronic wounds.
Exclusion Criteria
Patient with the uncontrolled diabetic mellitus.
Patient positive with HIV, HBsAG,VDRL.
Patient suffering from Osteomyelitis,Tuberculosis,Malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method slough, pus discharge will be reduced and granulation tissue appearsTimepoint: assessment on every 7th days
- Secondary Outcome Measures
Name Time Method healed woundTimepoint: 28 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Sindooradi Malahama's efficacy in Dushta Vrana wound healing?
How does Sindooradi Malahama compare to standard wound care in chronic skin infections like L088?
Are there specific biomarkers that predict response to Sindooradi Malahama in Dushta Vrana patients?
What are the potential adverse events associated with Sindooradi Malahama treatment in phase II trials?
What other Ayurvedic compounds or combination therapies are being studied for Dushta Vrana management?